login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
AURINIA PHARMACEUTICALS INC (AUPH) Stock News
USA
- NASDAQ:AUPH -
CA05156V1022
-
Common Stock
12.74
USD
-0.04 (-0.31%)
Last: 9/12/2025, 8:00:01 PM
12.74
USD
0 (0%)
After Hours:
9/12/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AUPH Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Chartmill
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Shows Strong Growth Metrics and Earnings Momentum
4 days ago - By: Investor's Business Daily
- Mentions:
UTHR
HALO
ARGX
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
19 days ago - By: Investor's Business Daily
- Mentions:
ARGX
HALO
RIGL
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
a month ago - By: Zacks Investment Research
Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know
a month ago - By: Investor's Business Daily
- Mentions:
GILD
INCY
KNSA
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?
a month ago - By: The Motley Fool
Aurinia (AUPH) Q2 Revenue Jumps 22%
a month ago - By: Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025
2 months ago - By: Benzinga
- Mentions:
BSAC
BGC
RMNI
MTZ
...
Earnings Scheduled For July 31, 2025
2 months ago - By: Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025
3 months ago - By: Aurinia Pharmaceuticals Inc.
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
3 months ago - By: Stocktwits
Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results
3 months ago - By: Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
4 months ago - By: Zacks Investment Research
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?
4 months ago - By: Aurinia Pharmaceuticals Inc.
New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis
4 months ago - By: Zacks Investment Research
- Mentions:
NRG
HBM
FOX
Company News for May 13, 2025
4 months ago - By: Stocktwits
- Mentions:
IWM
IWO
EXPE
Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens
4 months ago - By: Zacks Investment Research
- Mentions:
DERM
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates
4 months ago - By: Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
4 months ago - By: Benzinga
Uncovering Potential: Aurinia Pharmaceuticals's Earnings Preview
4 months ago - By: Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025
5 months ago - By: Aurinia Pharmaceuticals Inc.
Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
5 months ago - By: Aurinia Pharmaceuticals Inc.
ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
5 months ago - By: Yahoo Finance
- Mentions:
PEP
HRTG
MRX
VRTX
...
Tariff turmoil: What P&G, Pepsi and other companies are saying about tariffs
5 months ago - By: Zacks Investment Research
- Mentions:
ESPR
HRTX
PSTV
PYXS
5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms
6 months ago - By: Stocktwits
- Mentions:
MYNZ
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet
Please enable JavaScript to continue using this application.